In Brief: Schick Technologies' accuDEXA
This article was originally published in The Gray Sheet
Executive Summary
Schick Technologies' accuDEXA: Low-cost bone densitometry product is available following 510(k) clearance, Schick announces Dec. 2. The company is marketing the dual energy x-ray absorptiometry device, which measures bone density of the finger in 30 seconds, to physicians at a cost of $10,995 through its direct sales force and distributors. Schick notes that under the Health Care Financing Administration's 1998 reimbursement rates, physicians will be reimbursed at nearly $70 per test, "making potential return on investment on a $10,995 DEXA device very attractive"...